<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00136630</url>
  </required_header>
  <id_info>
    <org_study_id>RBM01-59 _ AOM03059</org_study_id>
    <nct_id>NCT00136630</nct_id>
  </id_info>
  <brief_title>Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations</brief_title>
  <official_title>Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <brief_summary>
    <textblock>
      The autosomal dominant spinocerebellar degenerations are a highly heterogeneous, clinically
      and genetically, group of rare diseases and of severe evolution. So far, the responsible
      genes for less than 50% of the cases are known and because of their rarity, there are no
      phenotype-genotype correlations and well-defined disease history.

      The aims of the project are to develop and validate quantitative tools of the cerebellar
      syndrome and of the spasticity, to establish links between the phenotype and the result of
      the molecular analysis, to identify new loci/genes responsible for these disorders, and to
      establish the natural history of the disease according to the genotype.

      To this end, a prospective and multicentric study is proposed for recruiting and evaluating,
      clinically, a cohort of 225 patients; 150 of them are already followed-up in the centers
      involved. A DNA collection will be set up in order to search for the implication of new loci
      and genes. A clinico-genetic database will be set up combining data from successive clinical
      evaluations and those of genotyping.

      This strategy will allow access to genetic counselling and molecular diagnosis (positive,
      presymptomatic or prenatal diagnoses), based on a rational strategy from phenotype-genotype
      correlations and the information concerning the relative frequency of the genes. The detailed
      description, with the help of new evaluation tools and of the follow-up of the natural
      history of the disease according to the genotype, constitutes a crucial step in the design of
      therapeutical trials in these orphan disorders. Furthermore, the regular follow-up by
      specialized centers will allow better care of the patients.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>May 2005</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Family-Based</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">225</enrollment>
  <condition>Spinocerebellar Ataxias</condition>
  <condition>Spastic Paraplegias</condition>
  <eligibility>
    <study_pop>
      <textblock>
        French population
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Progressive ataxia or paraplegia,

          -  Familial history of the disease (patients),

          -  Over 18 years of age

          -  No presentation of neurological or osteoarticular disorders

        Exclusion Criteria:

          -  Refusal to participate in the protocol,

          -  An unknown familial history,

          -  Presenting with an interrecurrent disorder making the evaluation of the disease
             (stroke, dementia) impossible
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexandra Dürr, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Broussolle Emmanuel, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpitaux Civils de Lyon</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pierre Labauge, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpitaux de Nîmes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cyril Goizet, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpitaux de Bordeaux</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Patrick Calvas, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpitaux de Toulouse</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean-Philippe Azulay, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Marseille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Didier Hannequin, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpitaux de Rouen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pierre Pollak, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpitaux de Grenoble</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital Pellegrin</name>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Neurologique Pierre Wertheimer</name>
      <address>
        <city>Lyon</city>
        <zip>69003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital La Timone</name>
      <address>
        <city>Marseille</city>
        <zip>13005</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Carémeau</name>
      <address>
        <city>Nîmes</city>
        <zip>30000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Pitié-Salpêtrière</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Charles Nicolle</name>
      <address>
        <city>Rouen</city>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Purpan</name>
      <address>
        <city>Toulouse</city>
        <zip>31000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.aphp.fr</url>
  </link>
  <results_reference>
    <citation>Klebe S, Durr A, Rentschler A, Hahn-Barma V, Abele M, Bouslam N, Schöls L, Jedynak P, Forlani S, Denis E, Dussert C, Agid Y, Bauer P, Globas C, Wüllner U, Brice A, Riess O, Stevanin G. New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14. Ann Neurol. 2005 Nov;58(5):720-9.</citation>
    <PMID>16193476</PMID>
  </results_reference>
  <results_reference>
    <citation>Stevanin G, Hahn V, Lohmann E, Bouslam N, Gouttard M, Soumphonphakdy C, Welter ML, Ollagnon-Roman E, Lemainque A, Ruberg M, Brice A, Durr A. Mutation in the catalytic domain of protein kinase C gamma and extension of the phenotype associated with spinocerebellar ataxia type 14. Arch Neurol. 2004 Aug;61(8):1242-8.</citation>
    <PMID>15313841</PMID>
  </results_reference>
  <results_reference>
    <citation>Stevanin G, Durr A, Dussert C, Penet C, Brice A. Mutations in the FGF14 gene are not a major cause of spinocerebellar ataxia in Caucasians. Neurology. 2004 Sep 14;63(5):936.</citation>
    <PMID>15365159</PMID>
  </results_reference>
  <results_reference>
    <citation>Waters MF, Minassian NA, Stevanin G, Figueroa KP, Bannister JP, Nolte D, Mock AF, Evidente VG, Fee DB, Müller U, Dürr A, Brice A, Papazian DM, Pulst SM. Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes. Nat Genet. 2006 Apr;38(4):447-51. Epub 2006 Feb 26.</citation>
    <PMID>16501573</PMID>
  </results_reference>
  <results_reference>
    <citation>Depienne C, Tallaksen C, Lephay JY, Bricka B, Poea-Guyon S, Fontaine B, Labauge P, Brice A, Durr A. Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases. J Med Genet. 2006 Mar;43(3):259-65. Epub 2005 Jul 31.</citation>
    <PMID>16055926</PMID>
  </results_reference>
  <results_reference>
    <citation>Depienne C, Fedirko E, Forlani S, Cazeneuve C, Ribaï P, Feki I, Tallaksen C, Nguyen K, Stankoff B, Ruberg M, Stevanin G, Durr A, Brice A. Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia. J Med Genet. 2007 Apr;44(4):281-4. Epub 2006 Nov 10.</citation>
    <PMID>17098887</PMID>
  </results_reference>
  <results_reference>
    <citation>Depienne C, Fedirko E, Faucheux JM, Forlani S, Bricka B, Goizet C, Lesourd S, Stevanin G, Ruberg M, Durr A, Brice A. A de novo SPAST mutation leading to somatic mosaicism is associated with a later age at onset in HSP. Neurogenetics. 2007 Aug;8(3):231-3. Epub 2007 Jun 28.</citation>
    <PMID>17597328</PMID>
  </results_reference>
  <results_reference>
    <citation>Hanein S, Dürr A, Ribai P, Forlani S, Leutenegger AL, Nelson I, Babron MC, Elleuch N, Depienne C, Charon C, Brice A, Stevanin G. A novel locus for autosomal dominant &quot;uncomplicated&quot; hereditary spastic paraplegia maps to chromosome 8p21.1-q13.3. Hum Genet. 2007 Nov;122(3-4):261-73. Epub 2007 Jun 28.</citation>
    <PMID>17605047</PMID>
  </results_reference>
  <results_reference>
    <citation>Ribaï P, Depienne C, Fedirko E, Jothy AC, Viveweger C, Hahn-Barma V, Brice A, Durr A. Mental deficiency in three families with SPG4 spastic paraplegia. Eur J Hum Genet. 2008 Jan;16(1):97-104. Epub 2007 Oct 24.</citation>
    <PMID>17957230</PMID>
  </results_reference>
  <results_reference>
    <citation>du Montcel ST, Charles P, Ribai P, Goizet C, Le Bayon A, Labauge P, Guyant-Maréchal L, Forlani S, Jauffret C, Vandenberghe N, N'guyen K, Le Ber I, Devos D, Vincitorio CM, Manto MU, Tison F, Hannequin D, Ruberg M, Brice A, Durr A. Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairment. Brain. 2008 May;131(Pt 5):1352-61. doi: 10.1093/brain/awn059. Epub 2008 Mar 31.</citation>
    <PMID>18378516</PMID>
  </results_reference>
  <results_reference>
    <citation>Goizet C, Boukhris A, Mundwiller E, Tallaksen C, Forlani S, Toutain A, Carriere N, Paquis V, Depienne C, Durr A, Stevanin G, Brice A. Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10. Hum Mutat. 2009 Feb;30(2):E376-85. doi: 10.1002/humu.20920.</citation>
    <PMID>18853458</PMID>
  </results_reference>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 25, 2005</study_first_submitted>
  <study_first_submitted_qc>August 26, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 29, 2005</study_first_posted>
  <last_update_submitted>January 27, 2012</last_update_submitted>
  <last_update_submitted_qc>January 27, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>dominant spinocerebellar degenerations</keyword>
  <keyword>new rate scales</keyword>
  <keyword>natural history</keyword>
  <keyword>molecular biology</keyword>
  <keyword>candidate genes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinocerebellar Ataxias</mesh_term>
    <mesh_term>Spinocerebellar Degenerations</mesh_term>
    <mesh_term>Paraplegia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

